Please turn JavaScript on
Gynecologic Oncology Update icon

Gynecologic Oncology Update

We bring you the latest updates from Gynecologic Oncology Update through a simple and fast subscription.

We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.

Unsubscribe at any time without hassle.

Gynecologic Oncology Update's title: Gynecologic Oncology Update

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.21 / day

Message History

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:

Case: A woman in her early 70s with endometrioid carcinoma of the ovary and a large solitary brain metastasis after primary debulking surgery and adjuvant carboplatin/paclitaxel — Professor Jonath...

Read full story

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:

Case: A woman in her late 60s with a germline BRCA2 mutation and heavily pretreated ovarian cancer receives weekly nab paclitaxel and relacorilant — Angeles Alvarez Secord, MD, MHSc (0:00)

Read full story

Featuring perspectives from Prof Susana Banerjee, including the following topics:

Case: A woman in her mid 50s with multiregimen-recurrent low-grade serous ovarian cancer and a KRAS G12V mutation who receives avutometinib/defactinib with response, asymptomatic creatine phosphokinase elevation and mild facial rash — Dr Stover (0:00)Case: A woman in her early 30s with recurr...

Read full story

Featuring perspectives from Prof Susana Banerjee, including the following topics:

Overview of the biology and treatment of low-grade serous ovarian cancer (0:00)Mechanism of action of avutometinib/defactinib (10:16)RAMP 201 Trial: Avutometinib/defactinib in recurrent low-grade serous ovarian cancer (14:32)Ongoing clinical trials in low-grade serous ovarian cancer (27:57)

Read full story